Summary: The Centers for Medicare & Medicaid Services modified its intestinal and multi-visceral transplantation coverage policy, effective May 15, 2026. Here's what billing teams need to do before that date.
CMS intestinal and multi-visceral transplantation coverage policy changes don't happen often — but when they do, the financial exposure is enormous. These are among the most complex and expensive procedures in the Medicare system, involving multiple organ combinations, highly specialized surgical teams, and post-transplant management that spans years. The effective date of May 15, 2026 gives billing teams a window to prepare, but it's a narrow one. This policy does not list specific CPT or HCPCS codes in the available documentation — we'll address what that means for your team below.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Intestinal and Multi-Visceral Transplantation |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Transplant surgery, gastroenterology, transplant nephrology, transplant hepatology, post-transplant medicine |
| Key Action | Audit your current transplant billing documentation and prior authorization workflows before May 15, 2026 |
CMS Intestinal and Multi-Visceral Transplantation Coverage Criteria and Medical Necessity Requirements 2026
Intestinal and multi-visceral transplantation sits in a narrow corner of Medicare coverage. CMS has historically covered these procedures only under tightly defined medical necessity criteria — and any modification to this coverage policy signals that those criteria are shifting.
The term "multi-visceral transplantation" covers a spectrum of procedures. At one end, you have isolated intestinal transplantation. At the other, you have full multi-visceral transplants that may include the stomach, duodenum, pancreas, liver, and intestine together. Each configuration carries different coverage implications, different diagnosis requirements, and different documentation burdens.
Whether CMS is tightening or expanding coverage criteria here matters enormously for your reimbursement. Transplant procedures carry facility and professional fees that can run into hundreds of thousands of dollars. A single claim denial on a transplant case doesn't just affect one revenue line — it triggers a cascade of downstream appeals, retro-authorization requests, and coordination-of-benefits disputes.
Medical necessity is the crux of every intestinal transplant claim. CMS requires that patients meet specific clinical thresholds before coverage applies. Historically, those thresholds have centered on intestinal failure with life-threatening complications — things like total parenteral nutrition (TPN) failure, recurrent sepsis related to central venous access, or irreversible liver disease caused by TPN dependency. If the modification touches any of these criteria, your clinical documentation templates need to change before May 15, 2026.
Prior authorization requirements for transplant procedures under Medicare are complex and vary based on transplant type and the facility's certification status. CMS certification for transplant centers is a prerequisite — not a formality. Billing for an intestinal or multi-visceral transplant at a facility that hasn't maintained its CMS transplant center certification will result in claim denial. Verify your facility's certification status now, not after the effective date.
The available policy documentation does not include a detailed summary of the specific changes made in this modification. That's a problem for billing teams. It means you can't rely on this summary alone — pull the full policy from the CMS source directly at the PayerPolicy link above, and compare it line by line against the prior version.
CMS Intestinal and Multi-Visceral Transplantation Exclusions and Non-Covered Indications
CMS has historically drawn hard lines around certain transplant configurations and patient populations. Understanding what's excluded is just as important as knowing what's covered.
Multi-visceral transplants performed outside of CMS-certified transplant centers are not covered. This isn't a documentation issue — it's a categorical exclusion. If the facility doesn't hold the right certification for the specific transplant type performed, the claim won't pay. Period.
Retransplantation has historically faced heightened scrutiny. CMS applies medical necessity review more aggressively to repeat transplants, and documentation requirements are correspondingly more demanding. If this modification touches retransplantation criteria, that affects a meaningful subset of long-term transplant patients.
Experimental or investigational transplant configurations — including certain composite visceral allografts that lack sufficient clinical evidence — have not historically met CMS medical necessity standards. Whether this modification changes that for any specific configuration is something your transplant program's medical director and billing compliance team need to assess together.
The absence of a detailed policy summary in the available documentation means we can't confirm exactly which exclusions this modification adds, removes, or modifies. Don't assume the exclusions are unchanged. Talk to your compliance officer before the May 15, 2026 effective date.
Coverage Indications at a Glance
The available policy documentation does not provide a detailed breakdown of covered indications. The table below reflects the historically recognized CMS coverage framework for intestinal and multi-visceral transplantation. Treat this as a starting point — not a substitute for the full policy text.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Isolated intestinal transplantation for intestinal failure with TPN failure | Covered (when criteria met) | Policy does not list specific codes | Medical necessity documentation required; CMS transplant center certification required |
| Multi-visceral transplantation for short bowel syndrome with liver failure | Covered (when criteria met) | Policy does not list specific codes | Requires documentation of irreversible intestinal failure and TPN-related complications |
| Combined liver-intestine transplantation | Covered (when criteria met) | Policy does not list specific codes | Certification requirements apply to both liver and intestinal transplant components |
| Retransplantation | Covered with heightened scrutiny | Policy does not list specific codes | Enhanced medical necessity documentation required; prior authorization essential |
| Transplant at non-CMS-certified facility | Not Covered | N/A | Categorical exclusion regardless of clinical indication |
| Experimental visceral allograft configurations | Not Covered / Investigational | N/A | Insufficient clinical evidence under CMS standards |
CMS Intestinal and Multi-Visceral Transplantation Billing Guidelines and Action Items 2026
Here's what your billing team and transplant program administrators need to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull and read the full policy now. The available documentation for this modification does not include a detailed policy summary. Go directly to the CMS source. Read the current version against the prior version. If PayerPolicy's version diff tool is available to you, use it — line-by-line comparisons are the fastest way to find what actually changed. |
| 2 | Verify your facility's CMS transplant center certification status. Certification is a coverage prerequisite for intestinal and multi-visceral transplantation billing. Confirm your facility holds current certification for each transplant type your program performs. If recertification is pending, escalate that timeline — a lapse in certification on or after May 15, 2026 means denied claims. |
| 3 | Audit your medical necessity documentation templates. If the modification changes the clinical criteria for coverage, your pre-operative documentation needs to reflect the new thresholds. Work with your transplant medical director to update templates before the effective date. Don't wait for a denial to find out the documentation is insufficient. |
| 4 | Review your prior authorization workflow for transplant cases. Prior authorization for these procedures is non-negotiable. Confirm that your team's prior auth requests include all elements CMS now requires under the modified coverage policy. If you're not sure what those elements are, contact your Medicare Administrative Contractor directly for guidance. |
| 5 | Check all post-transplant immunosuppression billing. Intestinal and multi-visceral transplant patients require lifetime immunosuppression. Medicare Part D covers most immunosuppressants, but there are Part B-covered exceptions. Any modification to the transplant coverage policy can ripple into post-transplant medication coverage. Audit your current billing for post-transplant drugs against current Part B vs. Part D assignment rules. |
| 6 | Coordinate with your MAC before May 15, 2026. Medicare Administrative Contractors sometimes issue supplemental guidance on CMS policy modifications — especially for high-complexity procedures like these. Contact your MAC's provider outreach line and ask specifically about any local coverage determination guidance they're developing in response to this modification. |
| 7 | Loop in your compliance officer and revenue cycle leadership now. The financial stakes on transplant cases are too high to let a policy modification catch you unprepared. If you're not certain how this change applies to your program's specific case mix, get your compliance officer, billing consultant, and transplant program administrator in the same room before May 15, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Intestinal and Multi-Visceral Transplantation Under This Policy
The available policy documentation does not list specific CPT, HCPCS, or ICD-10 codes. This is not uncommon for CMS intestinal and multi-visceral transplantation coverage policy documents — the clinical complexity means that code assignment often depends on the specific organ combination transplanted and the surgical approach used.
Do not treat the absence of codes in this summary as confirmation that your current code set is correct. Pull the full policy from CMS directly. Cross-reference your current charge capture against the transplant surgery coding guidelines in the CPT codebook, and verify ICD-10-CM diagnosis coding against the clinical documentation in each case.
Intestinal and multi-visceral transplantation billing involves highly specialized CPT codes for organ procurement, back-table preparation, and transplant implantation. Each organ component in a multi-visceral transplant may carry its own procedure code. Inaccurate or incomplete code sets are a primary driver of claim denial in transplant billing — and a policy modification is exactly the kind of trigger that can expose gaps in your charge capture.
If your revenue cycle team doesn't have a transplant billing specialist, this is the moment to engage one. The reimbursement at stake on a single case justifies the investment.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.